82
28. PINGE-FILHO, P.; et al. Protective immunity against Trypanosoma cruzi
provided by oral immunization with Phytomonas serpens: role of nitric oxide.
Immunology Letters, 96, p. 283-290, 2005.
29. PIZZOLATTI, M.G.; KOGA, A.H.; GRISARD, E.C.; STEINDEL, M.
Trypanocidal activity of extracts from brazilian atlantic rain forest plant
species. Phytomedicine, 10 (5), p. 422-426, 2003.
30. POZAS, R.; CARBALLO, J.; CASTRO, C. e RUBIO, J. Synthesis and in vitro
antitrypanosomal activity of novel nifurtimox analogues. Bioorganic &
Medicinal Chemistry Letters, 15, p. 1417-1421, 2005.
31. QUAST, H.; SHÖN, N. Synthese und reaktionen einiger pyrido[3,2-g]chinoline
(1,8-diazaanthracene). Liebigs Ann. Chem., p. 133-146, 1984.
32. RANG, H.P.; DALE, M.M. Farmacologia. In: 44 – Princípios Básicos da
Quimioterapia. 3
a
ed. Rio de Janeiro: Elsevier Editora Ltda, p. 704, 705, 2003.
33. RATH, S.; et al. Antimoniais empregados no tratamento da leishmaniose:
estado e arte. Química Nova, 26(4), p. 550-555, 2003.
34. ROMANHA, A.J.; ALVES, R.O.; MURTA, S.M.F.; SILVA, J.S; ROPERT, C.;
GAZZINELLI, R.T. Experimental chemotherapy against Trypanosoma cruzi
infection: essential role of endogenous Interferon-γ in mediating parasitologic
cure. The Journal of Infection Diseases, 186, p. 823-828, 2002.
35. SARTORIUS, J.; SCHEIDER, H.J. Intercalation mechanisms with ds-DNA:
binding modes and energy contributions with benzene, naphthalene, quinoline
and indole derivatives including some antimalarials. J. Chem. Soc., Perkin
Trans. 2, p. 2319-2327, 1997.